P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION.

Detalles Bibliográficos
Autores principales: Callegari, Chiara, Mutti, Martina, Soravia, Alessandra, Lauzzana, Pietro, Lazzarotto, Davide, Peghin, Maddalena, Cordella, Stefano, Fanin, Renato, Candoni, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429838/
http://dx.doi.org/10.1097/01.HS9.0000972932.76052.0f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429838/
http://dx.doi.org/10.1097/01.HS9.0000972932.76052.0f

Ejemplares similares